Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
680 participants
INTERVENTIONAL
2004-11-08
2006-03-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults
NCT00238784
Randomized, Placebo-controlled Study Comparing Efficacy of Fluticasone/Salmeterol Combination to Advair in Asthmatics
NCT02496715
SHARE - Symbicort and Health Economics in a Real Life Evaluation
NCT00259766
Cross-sectional Study for Identification and Description of Severe Asthma Patients
NCT02293265
A Study to Investigate the Efficacy, Safety, and Tolerability of Repeat Doses of Inhaled GSK2269557 in Adults With Persistent, Uncontrolled Asthma
NCT02567708
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
salmeterol xinafoate/fluticasone propionate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* History of heavy smoking or substance abuse.
* Females who are pregnant or lactating.
* Required emergency room treatment for their asthma 12 weeks prior to Visit 1.
* Serious, uncontrolled, systemic disease that may make study participation unsafe or inappropriate in the opinion of the physician.
* Other medical criteria will be evaluated at the screening visit.
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GSK Clinical Trials
Role: STUDY_DIRECTOR
GlaxoSmithKline
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GSK Investigational Site
Calgary, Alberta, Canada
GSK Investigational Site
Calgary, Alberta, Canada
GSK Investigational Site
Edmonton, Alberta, Canada
GSK Investigational Site
Edmonton, Alberta, Canada
GSK Investigational Site
Edmonton, Alberta, Canada
GSK Investigational Site
Edmonton, Alberta, Canada
GSK Investigational Site
Abbotsford, British Columbia, Canada
GSK Investigational Site
Abbotsford, British Columbia, Canada
GSK Investigational Site
Burnaby, British Columbia, Canada
GSK Investigational Site
Chilliwack, British Columbia, Canada
GSK Investigational Site
Coquitlam, British Columbia, Canada
GSK Investigational Site
Delta, British Columbia, Canada
GSK Investigational Site
Kamloops, British Columbia, Canada
GSK Investigational Site
Kelowna, British Columbia, Canada
GSK Investigational Site
Maple Ridge, British Columbia, Canada
GSK Investigational Site
Penticton, British Columbia, Canada
GSK Investigational Site
Richmond, British Columbia, Canada
GSK Investigational Site
Surrey, British Columbia, Canada
GSK Investigational Site
Vancouver, British Columbia, Canada
GSK Investigational Site
Brandon, Manitoba, Canada
GSK Investigational Site
Steinbach, Manitoba, Canada
GSK Investigational Site
Winnipeg, Manitoba, Canada
GSK Investigational Site
Winnipeg, Manitoba, Canada
GSK Investigational Site
Winnipeg, Manitoba, Canada
GSK Investigational Site
Moncton, New Brunswick, Canada
GSK Investigational Site
Rothesay, New Brunswick, Canada
GSK Investigational Site
Bay Roberts, Newfoundland and Labrador, Canada
GSK Investigational Site
Holyrood, Newfoundland and Labrador, Canada
GSK Investigational Site
Mount Pearl, Newfoundland and Labrador, Canada
GSK Investigational Site
Mount Pearl, Newfoundland and Labrador, Canada
GSK Investigational Site
St. John's, Newfoundland and Labrador, Canada
GSK Investigational Site
St. John's, Newfoundland and Labrador, Canada
GSK Investigational Site
Bridgewater, Nova Scotia, Canada
GSK Investigational Site
Halifax, Nova Scotia, Canada
GSK Investigational Site
Halifax, Nova Scotia, Canada
GSK Investigational Site
Upper Tantallon, Nova Scotia, Canada
GSK Investigational Site
Ajax, Ontario, Canada
GSK Investigational Site
Barrie, Ontario, Canada
GSK Investigational Site
Bolton, Ontario, Canada
GSK Investigational Site
Brampton, Ontario, Canada
GSK Investigational Site
Brampton, Ontario, Canada
GSK Investigational Site
Brantford, Ontario, Canada
GSK Investigational Site
Burlington, Ontario, Canada
GSK Investigational Site
Fort Erie, Ontario, Canada
GSK Investigational Site
Greater Sudbury, Ontario, Canada
GSK Investigational Site
Greater Sudbury, Ontario, Canada
GSK Investigational Site
Hamilton, Ontario, Canada
GSK Investigational Site
Hamilton, Ontario, Canada
GSK Investigational Site
Hamilton, Ontario, Canada
GSK Investigational Site
Hamilton, Ontario, Canada
GSK Investigational Site
Kanata, Ontario, Canada
GSK Investigational Site
Kingston, Ontario, Canada
GSK Investigational Site
Kitchener, Ontario, Canada
GSK Investigational Site
London, Ontario, Canada
GSK Investigational Site
London, Ontario, Canada
GSK Investigational Site
London, Ontario, Canada
GSK Investigational Site
London, Ontario, Canada
GSK Investigational Site
London, Ontario, Canada
GSK Investigational Site
London, Ontario, Canada
GSK Investigational Site
London, Ontario, Canada
GSK Investigational Site
Mississauga, Ontario, Canada
GSK Investigational Site
Mississauga, Ontario, Canada
GSK Investigational Site
Mississauga, Ontario, Canada
GSK Investigational Site
Mississauga, Ontario, Canada
GSK Investigational Site
Mississauga, Ontario, Canada
GSK Investigational Site
Newmarket, Ontario, Canada
GSK Investigational Site
Niagara Falls, Ontario, Canada
GSK Investigational Site
Niagara Falls, Ontario, Canada
GSK Investigational Site
North Bay, Ontario, Canada
GSK Investigational Site
North York, Ontario, Canada
GSK Investigational Site
North York, Ontario, Canada
GSK Investigational Site
North York, Ontario, Canada
GSK Investigational Site
North York, Ontario, Canada
GSK Investigational Site
Oshawa, Ontario, Canada
GSK Investigational Site
Oshawa, Ontario, Canada
GSK Investigational Site
Oshawa, Ontario, Canada
GSK Investigational Site
Peterborough, Ontario, Canada
GSK Investigational Site
Prescott, Ontario, Canada
GSK Investigational Site
Renfrew, Ontario, Canada
GSK Investigational Site
Richmond Hill, Ontario, Canada
GSK Investigational Site
Richmond Hill, Ontario, Canada
GSK Investigational Site
Saint Catherines, Ontario, Canada
GSK Investigational Site
Scarborough Village, Ontario, Canada
GSK Investigational Site
Thornhill, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Toronto, Ontario, Canada
GSK Investigational Site
Trenton, Ontario, Canada
GSK Investigational Site
Windsor, Ontario, Canada
GSK Investigational Site
Windsor, Ontario, Canada
GSK Investigational Site
Windsor, Ontario, Canada
GSK Investigational Site
Windsor, Ontario, Canada
GSK Investigational Site
Brossard, Quebec, Canada
GSK Investigational Site
Charlesbourg, Quebec, Canada
GSK Investigational Site
Châteauguay, Quebec, Canada
GSK Investigational Site
Chicoutimi, Quebec, Canada
GSK Investigational Site
Contrecoeur, Quebec, Canada
GSK Investigational Site
Courcelette, Quebec, Canada
GSK Investigational Site
Cowansville, Quebec, Canada
GSK Investigational Site
LaSalle, Quebec, Canada
GSK Investigational Site
LaSalle, Quebec, Canada
GSK Investigational Site
LeGardeur, Quebec, Canada
GSK Investigational Site
Longueuil, Quebec, Canada
GSK Investigational Site
Montreal, Quebec, Canada
GSK Investigational Site
Montreal, Quebec, Canada
GSK Investigational Site
Montreal, Quebec, Canada
GSK Investigational Site
Montreal, Quebec, Canada
GSK Investigational Site
Montreal, Quebec, Canada
GSK Investigational Site
Montreal, Quebec, Canada
GSK Investigational Site
Princeville, Quebec, Canada
GSK Investigational Site
Saine-Eustache, Quebec, Canada
GSK Investigational Site
Saint Romuald, Quebec, Canada
GSK Investigational Site
Sainte Jerome, Quebec, Canada
GSK Investigational Site
Sainte-Catherine, Quebec, Canada
GSK Investigational Site
Sainte-Foy, Quebec, Canada
GSK Investigational Site
St-Bruno, Quebec, Canada
GSK Investigational Site
Trois-Rivières, Quebec, Canada
GSK Investigational Site
Trois-Rivières, Quebec, Canada
GSK Investigational Site
Ville Lasalle, Quebec, Canada
GSK Investigational Site
Regina, Saskatchewan, Canada
GSK Investigational Site
Regina, Saskatchewan, Canada
GSK Investigational Site
Saskatoon, Saskatchewan, Canada
GSK Investigational Site
Saskatoon, Saskatchewan, Canada
GSK Investigational Site
Québec, , Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SFA103081
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.